Clinical Trial Update: Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With PAD and Claudication [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 trial evaluating sonodynamic therapy for regression of atherosclerosis in patients with peripheral arterial disease and claudication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Arterial Disease

Drugs mentioned

• Sonodynamic Therapy

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Peripheral Arterial Disease, Atherosclerosis | Phase 1, Phase 2 | Status: COMPLETED